Back

Salarius Pharmaceuticals to Report Second Quarter 2021 Financial Results

Read More

Back

Salarius Pharmaceuticals Announces Aundrietta Duncan, Ph.D., To Present During Virtual Epigenetic Therapeutic Targets Summit

Read More

Back

Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas

Read More

Back

Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference

Read More